These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 4735276)
1. Use of the Fluotec Mark II for halothane-air anesthesia. Counts HK; Carden WD; Petty WC Anesth Analg; 1973 Mar; 52(2):181-7. PubMed ID: 4735276 [No Abstract] [Full Text] [Related]
2. Simplified airway management during anesthesia or resuscitation. A binasal pharyngeal system. Elam JO; Titel JH; Feingold F; Weisman H; Bauer RO Anesth Analg; 1969; 48(2):307-16. PubMed ID: 5251280 [No Abstract] [Full Text] [Related]
3. Effect of various carrier gases on the halothane output of the Fluotec Mark 3 vaporizer. Haskins SC; Knapp RG Am J Vet Res; 1980 Jan; 41(1):153-4. PubMed ID: 7189100 [TBL] [Abstract][Full Text] [Related]
4. Fluotec Mark 2 halothane output: nonlinearity from "off" to 0.5 per cent dial settings. Murray WJ; Fleming P Anesthesiology; 1972 Feb; 36(2):180-1. PubMed ID: 5059110 [No Abstract] [Full Text] [Related]
5. Administration of halothane in the 0-0.5 per cent concentration range with the Fluotec Mark 2 and Mark 3 vaporizers. Latto IP Br J Anaesth; 1973 Jun; 45(6):563-9. PubMed ID: 4718247 [No Abstract] [Full Text] [Related]
6. [The Fluotec Mark II with built-in pressure adjustment valve]. Kapfhammer V; Atabas A Anaesthesist; 1965 Sep; 14(9):257-9. PubMed ID: 5325226 [No Abstract] [Full Text] [Related]
7. EFFECT OF NITROUS OXIDE AND OF NARCOTIC PREMEDICATION ON THE ALVEOLAR CONCENTRATION OF HALOTHANE REQUIRED FOR ANESTHESIA. SAIDMAN LJ; EGER EI Anesthesiology; 1964; 25():302-6. PubMed ID: 14156570 [No Abstract] [Full Text] [Related]
9. [Concentration of halothane delivered by Fluotec Mark II and in the vapor of the Dräger vaporizer at the "lock-off" position]. Yanagawa F; Fujita T Masui; 1975 Jul; 24(7):695-8. PubMed ID: 1172539 [No Abstract] [Full Text] [Related]
10. The effect of nitrous oxide on halothane output from Fluotec Mark 2 vaporizers. Stoelting RK Anesthesiology; 1971 Aug; 35(2):215-8. PubMed ID: 5568139 [No Abstract] [Full Text] [Related]
12. Evaluation of a new halothane vaporizer: the Cyprane Fluotec Mark 3. Paterson GM; Hulands GH; Nunn JF Br J Anaesth; 1969 Feb; 41(2):109-19. PubMed ID: 5774514 [No Abstract] [Full Text] [Related]
13. A laboratory comparison of Copper Kettle, Fluotec Mark 2, and Pentec vaporizers. Gartner J; Stoelting RK Anesth Analg; 1974; 53(2):187-90. PubMed ID: 4150154 [No Abstract] [Full Text] [Related]
14. [ANESTHESIA AND RESUSCITATION ACUTE ABDOMEN OF INFANCY]. ZUCCOLI G; BONO F Riforma Med; 1963 Oct; 77():1128-30. PubMed ID: 14099302 [No Abstract] [Full Text] [Related]
15. Quantitative closed-circuit halothane anesthesia. A clinical study employing a new pressurized temperature-compensated vaporizer. Titel JH; Lowe HJ; Elam JO; Grosholz JR Anesth Analg; 1968; 47(5):560-9. PubMed ID: 4876885 [No Abstract] [Full Text] [Related]
16. Assessment of vaporizer performance in low-flow and closed-circuit anesthesia. Lin CY Anesth Analg; 1980 May; 59(5):359-66. PubMed ID: 6989290 [TBL] [Abstract][Full Text] [Related]
17. HALOTHANE AS AN INDUCTION AGENT. HOLMES CM; BRYCE-SMITH R Anaesthesia; 1964 Jul; 19():399-407. PubMed ID: 14174640 [No Abstract] [Full Text] [Related]
18. The influence of carrier gas on the output of automatic plenum vaporizers. Diaz PM Br J Anaesth; 1976 Apr; 48(4):387-91. PubMed ID: 1276004 [TBL] [Abstract][Full Text] [Related]
19. A study of halothane-diethyl ether azeotrope and the Oxford miniature vaporizer. Bengtsson M; Malmqvist LA; Löfström JB Acta Anaesthesiol Scand; 1986 Apr; 30(3):218-22. PubMed ID: 3739579 [TBL] [Abstract][Full Text] [Related]
20. Inadvertent administration of halothane with the Fluotec Mk. 3 vaporiser. Bar ZG Anaesth Intensive Care; 1984 Nov; 12(4):378. PubMed ID: 6517303 [No Abstract] [Full Text] [Related] [Next] [New Search]